Patent intelligence · US
US 2011206613
METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT
METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT
Patent details — US 2011206613
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 25, 2011
- Expiration
- Aug 20, 2031
- Applicant
- WIEHE ARNO [DE]
- CPC classes
- A61K 31/ 409 A I, A61K 31/ 7056 A I, A61K 49/ 00 A I, A61P 19/ 02 A I
Quick answer
US 2011206613 (METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT) is held by WIEHE ARNO [DE]. Status: granted. Granted Aug 25, 2011. Expires Aug 20, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- WIEHE ARNO [DE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 409 A I, A61K 31/ 7056 A I, A61K 49/ 00 A I, A61P 19/ 02 A I, A61P 29/ 00 A I, A61P 43/ 00 A I
More from WIEHE ARNO [DE]
Related pharmaceutical patents in our USPTO index.
-
BR PI0714667
conjugado molecular e respectivo uso
granted -
MX 2013000877
APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT.
granted -
US 2013041307
APPLICATION OF BETA-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT
granted -
WO 2013015774
DIHYDROXY-CHLORINES GLYCO-SUBSTITUÉES ET CHLORINES BÊTA-FONCTIONNALISÉES POUR THÉRAPIE ANTIMICROBIENNE PHOTODYNAMIQUE
granted -
BR PI0614453
método de redução de cululite indesejada em áreas seletivas de um organismo e mistura fotossensibilizante
granted -
US 2012263625
GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY
granted -
US 2012259187
DYNAMIC COLORECTAL PDT APPLICATION
granted
Frequently asked questions
What is US patent 2011206613?
US 2011206613 (METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT) is held by WIEHE ARNO [DE]. Status: granted. Granted Aug 25, 2011. Expires Aug 20, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 2011206613?
WIEHE ARNO [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does US 2011206613 expire?
Our index shows an expiration date of Aug 20, 2031 (5 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.